Program
lobeglitazone
Also written as “CKD-501 0.5mg”, “CKD-501” and “CKD-501, D745, D150”.
Its studies are mostly in Diabetes Mellitus, Type 2 · Renal Insufficiency · Liver Diseases, led by Chong Kun Dang Pharmaceutical.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Chong Kun Dang Pharmaceutical | 250 open or running | phase 3since Oct 23, 2009 | Oct 23, 2009 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 6 studies since Oct 23, 2009.
- Apr 5, 20112 phase 1 studies in Diabetes Mellitus, Type 2NCT01330563, NCT01341392
- Nov 25, 2013Phase 1 study in Diabetes Mellitus, Type 2NCT02002611 · 24 enrolled · Korea, Republic of
- Dec 3, 20132 phase 1 studiesNCT02007941, NCT02005744
- Sep 23, 2015Phase 1 study in Diabetes Mellitus, Type 2NCT02565368 · 26 enrolled · Korea, Republic of
- Dec 21, 2015Phase 1 study in Diabetes Mellitus, Type 2NCT02648854 · 26 enrolled · Korea, Republic of
- Jun 30, 2016Phase 1 study in Diabetes Mellitus, Type 2NCT02824874 · 20 enrolled · Korea, Republic of
- Aug 1, 2016Phase 1 study in Diabetes Mellitus, Type 2NCT02854748 · 30 enrolled · Korea, Republic of
- Feb 22, 2018Phase 3 study in Type2 DiabetesNCT03739125 · 226 enrolled · Korea, Republic of
- Jul 4, 20182 phase 3 studies in Type2 DiabetesNCT03627182, NCT03641352
- Jul 8, 2018Phase 1 study in Diabetes Mellitus, Type 2NCT03616392 · 41 enrolled · Korea, Republic of
- Mar 31, 2020Phase 1 study in Diabetes Mellitus, Type 2NCT04334213 · 48 enrolled · Korea, Republic of
- Jun 11, 2020Phase 1 study in Diabetes Mellitus, Type 2NCT04431687 · 48 enrolled · Korea, Republic of
- Jan 10, 2021Phase 1 study in Diabetes Mellitus, Type 2NCT04706286 · 26 enrolled · Korea, Republic of
- Dec 14, 20253 phase 1 studies in Diabetes Mellitus, Type 2NCT07304726, NCT07304700, NCT07304687
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 25 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07304726Diabetes Mellitus, Type 2 · South Korea | 1 | Completed | Nov 9, 2025 | 30 |
| NCT07304700Diabetes Mellitus, Type 2 · South Korea | 1 | Completed | Nov 7, 2025 | 30 |
| NCT07304687Diabetes Mellitus, Type 2 · South Korea | 1 | Completed | Nov 3, 2025 | 31 |
| NCT04706286Diabetes Mellitus, Type 2 · Korea, Republic of | 1 | UNKNOWN | Mar 29, 2021 | 26 |
| NCT04431687Diabetes Mellitus, Type 2 · Korea, Republic of | 1 | Completed | Jul 24, 2020 | 48 |
| NCT04334213Diabetes Mellitus, Type 2 · Korea, Republic of | 1 | Completed | Aug 5, 2020 | 48 |
| NCT03641352Type2 Diabetes · Korea, Republic of | 3 | UNKNOWN | Apr 30, 2021 | 240 |
| NCT03616392Diabetes Mellitus, Type 2 · Korea, Republic of | 1 | Completed | Sep 17, 2018 | 41 |
| NCT03627182Type2 Diabetes · Korea, Republic of | 3 | UNKNOWN | Mar 29, 2022 | 240 |
| NCT03739125Type2 Diabetes · Korea, Republic of | 3 | Completed | May 25, 2020 | 226 |
| NCT02854748Diabetes Mellitus, Type 2 · Korea, Republic of | 1 | UNKNOWN | Sep 2016 | 30 |
| NCT02824874Diabetes Mellitus, Type 2 · Korea, Republic of | 1 | Completed | Apr 2016 | 20 |
| NCT02648854Diabetes Mellitus, Type 2 · Korea, Republic of | 1 | Completed | Oct 2015 | 26 |
| NCT02565368Diabetes Mellitus, Type 2 · Korea, Republic of | 1 | Completed | Aug 2015 | 26 |
| NCT02005744Liver Diseases · Korea, Republic of | 1 | Completed | Feb 2016 | 26 |
| NCT02007941Renal Insufficiency · Korea, Republic of | 1 | Completed | Apr 2015 | 28 |
| NCT02002611Diabetes Mellitus, Type 2 · Korea, Republic of | 1 | Completed | Feb 2014 | 24 |
| NCT01341392Diabetes Mellitus, Type 2 · Korea, Republic of | 1 | Completed | Aug 2011 | 25 |
| NCT01330563Diabetes Mellitus, Type 2 · Korea, Republic of | 1 | Completed | Jun 2011 | 24 |
| NCT01133431Healthy Male Volunteer · Korea, Republic of | 1 | Completed | Jun 2010 | 24 |
| NCT01106131Diabetes Mellitus, Type 2 · Korea, Republic of | 3 | Completed | Apr 2012 | 253 |
| NCT01071720Healthy | 1 | Completed | Jun 2010 | 24 |
| NCT01030679Diabetes Mellitus, Type 2 · Korea, Republic of | 2 | Completed | Oct 2008 | 214 |
| NCT01005160Healthy Male Volunteers | 1 | Completed | Dec 2009 | 24 |
| NCT01001611Diabetes Mellitus, Type 2 · South Korea | 3 | Completed | Jan 2012 | 173 |
How it is read
Names in the registry
- “CKD-501 0.5mg”, 6 entries
- “CKD-501”, 5 entries
- “CKD-501, D745, D150”, 3 entries
- “CKD-501, D759, D150”, 2 entries
- “CKD-395 0.5(Lobeglitazone)/1000(Metformin)mg 1T”, 2 entries
Conditions, from the studies’ own filings
- Diabetes Mellitus, Type 2, 20 studies
- Renal Insufficiency, 1 study
- Liver Diseases, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.